Skip to main content
OpenTrials
Completed

NCT Number: NCT01522690

Assessment of Accelerometric Measurement Devices for Gait Analysis

The objective of this study is to obtain normative accelerometry data during the six minute walk test and a 30 second walk test on healthy subjects in order to determine the accelerometric variables that are the most relevant to describe gait disorders in patient populations. Secondary objectives of this study are to investigate the impact of walking speed and muscle strength on the accelerometric parameters, to assess the reproducibility of the method and to compare accelerometric data obtained with two different devices.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

5 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institut de Myologie - GH Pitié Salpêtrière

Paris, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy ambulant subject
  • subject affiliated to a social security system
  • subject who signed an informed consent

Exclusion criteria

  • surgery or recent trauma to the lower limbs (under 6 months)
  • high performance sport
  • chronic treatment alters the strength in the month before inclusion
  • pregnant or nursing woman
  • person under guardianship or curatorship
  • orthopedic, neuromuscular or neurological disease having an impact on the quality of walking

Treatment and study plan

Different walk tests with an accelerometer device

Other

Subjects will performed three walk tests of 50 meter at different speeds, a six minute walk test, a walking test of 30 seconds then a test to measure the maximum force of extension and knee flexion on each leg. The walk tests will be performed with the accelerometer device (Locometrix) worn in a belt

Primary outcomes

  1. Accelerometric variables measured for each walk test

    Time frame: At baseline

  2. Accelerometric variables measured for each walk test

    Time frame: 1 hour after baseline

Secondary outcomes

  1. Gait speed measured for each walk test

    Time frame: At baseline

  2. Knee flexion and extension strength

    Time frame: At baseline

  3. Gait speed measured for each walk test

    Time frame: 1 hour after baseline

Sponsors and collaborators

Lead sponsor

Institut de Myologie, France

Other

Registry information

Acronym: ACCELERIX

Important dates

Study start
2011
Primary completion
2015
Study completion
2015
First posted
Feb 1, 2012
Registry last updated
Apr 15, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.